The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia
Open Access
- 1 November 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (48) , 79187-79202
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Fengyan Jin1, Hai Lin1, Sujun Gao1, Zheng Hu2, Song Zuo2, Liguang Sun2, Chunhui Jin1, Wei Li1, Yanping Yang1 1Department of Hematology, The First Bethune Hospital of Jilin University, Changchun, China 2Institute of Translational Medicine, The First Bethune Hospital of Jilin University, Changchun, China Correspondence to: Yanping Yang, email: yangyanping_1978@163.com Keywords: natural killer cells, interleukin, interferon-γ, NKG2D, leukemia Received: December 13, 2015 Accepted: October 26, 2016 Published: November 01, 2016Keywords
This publication has 52 references indexed in Scilit:
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer CellsTransplantation and Cellular Therapy, 2014
- NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantationClinical and Experimental Immunology, 2013
- TCR signaling requirements for activating T cells and for generating memoryCellular and Molecular Life Sciences, 2012
- Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infectionBlood, 2010
- Cytokine-induced memory-like natural killer cellsProceedings of the National Academy of Sciences, 2009
- IL-21 Enhances Tumor Rejection through a NKG2D-Dependent MechanismThe Journal of Immunology, 2005
- RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates TumorigenicityIn vivoCancer Research, 2004
- IL-2-Activated CD8+CD44high Cells Express Both Adaptive and Innate Immune System Receptors and Demonstrate Specificity for Syngeneic Tumor CellsThe Journal of Immunology, 2003
- Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignanciesTransplantation, 2003